Nephrotoxicity of ifosfamide--moving towards understanding the molecular mechanisms.
Rossi
R
R
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects* / Q000378:metabolism; D003520:Cyclophosphamide / Q000009:adverse effects; D004247:DNA / Q000378:metabolism; D005198:Fanconi Syndrome / Q000139:chemically induced*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects* / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000378:metabolism; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000378:metabolism; D015080:Mesna / Q000378:metabolism / Q000633:toxicity; D051381:Rats
D018906:Antineoplastic Agents, Alkylating; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D004247:DNA; D015080:Mesna; D007069:Ifosfamide